LifeStance Health (LFST) Acquisitions (2020 - 2026)

LifeStance Health (LFST) has 5 years of Acquisitions data on file, last reported at $3.1 million in Q1 2026.

• Quarterly Acquisitions changed N/A year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (changed N/A YoY) and the FY2023 annual result came in at $19.8 million, down 67.08% from the prior year.
• Acquisitions fell to $3.1 million in Q1 2026 per LFST's latest filing, from $19.8 million in the prior quarter.
• Across five years, Acquisitions topped out at $22.9 million in Q1 2022 and bottomed at $3.1 million in Q1 2026.
• The 3-year median for Acquisitions is $16.0 million (2022), against an average of $13.9 million.
• Peak annual rise in Acquisitions reached 2943.1% in 2022, while the deepest fall reached 51.3% in 2022.
• Tracing LFST's Acquisitions over 3 years: stood at $19.9 million in 2022, then fell by 0.46% to $19.8 million in 2023, then slumped by 84.14% to $3.1 million in 2026.
• Per Business Quant, the three latest LFST Acquisitions figures stand at $3.1 million (Q1 2026), $19.8 million (Q1 2023), and $19.9 million (Q4 2022).

Peer Comparison